GenetiRate developed a proprietary diagnostic assay and automated sorting platform for aquatic eggs, embryos, hatchlings, and tissue samples
GenetiRate developed a proprietary diagnostic assay and automated sorting platform for aquatic eggs, embryos, hatchlings, and tissue samples. Its system assesses metabolic rate and classifies biological traits associated with growth potential and feed efficiency, helping aquaculture producers select higher-performing stock. The company was acquired by IMV Technologies in 2021.